Sinopharm
1099.HK
#2268
Rank
NZ$11.10 B
Marketcap
$3.56
Share price
0.23%
Change (1 day)
-27.21%
Change (1 year)
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.

Sinopharm (1099.HK) - Total debt

Total debt on the balance sheet as of December 2023 : NZ$16.87 B

According to Sinopharm's latest financial reports the company's total debt is NZ$16.87 B. A companyโ€™s total debt is the sum of all current and non-current debts.

Sinopharm - Total debt on balance sheet (from 2008 to 2023)

Total debt by year

Year Total debt Change
2022-12-31NZ$21.58 B37.76%
2021-12-31NZ$15.66 B7.24%
2020-12-31NZ$14.60 B24.85%
2019-12-31NZ$11.70 B-2%
2018-12-31NZ$11.93 B48.12%
2017-12-31NZ$8.06 B15.74%
2016-12-31NZ$6.96 B6.54%
2015-12-31NZ$6.53 B7.8%
2014-12-31NZ$6.06 B19.88%
2013-12-31NZ$5.05 B60.2%
2012-12-31NZ$3.15 B11.83%
2011-12-31NZ$2.82 B317.62%
2010-12-31NZ$0.67 B93.72%
2009-12-31NZ$0.34 B-16.06%
2008-12-31NZ$0.41 B1.03%
2007-12-31NZ$0.41 B20.24%
2006-12-31NZ$0.34 B